Judicialization of health: profile of demands for oncological medicines in a state in the central region of Brazil

Int J Equity Health. 2022 Aug 17;21(1):112. doi: 10.1186/s12939-022-01704-6.

Abstract

Background: The significant increase in access to oncological medicines through court cases suggests that constitutional guarantees of integral and universal care in the Brazilian public health system are uncertain.

Methods: A retrospective observational study was conducted to analyze data from lawsuits requesting oncological medicines from 2014 to 2020 in the State of Goiás, Brazil, in state and federal courts. Sociodemographic, medical, and legal variables were statistically examined using descriptive, association, and correlation methods.

Results: Women brought more than half (54%) of the 301 processes analyzed. The most frequent age group was over 55 years, with income below 3 × the minimum wage (total about USD$600/month), and their cases were promoted through the public minister and public defender's offices. The most requested medications, not on official public health system lists, were indicated for multiple myeloma and brain cancer.

Conclusions: Improved quality of life, frequently used as a justification, could be conceptually confused with increased survival. Finally, judicialization itself indicates that individual health needs arise even with properly defined and adequately implemented public policies. These needs should be considered for the adequate provisioning of services by the state to ensure the right to health.

Keywords: Antineoplastic Agents; Judicialization of health; Quality of life.

Publication types

  • Observational Study

MeSH terms

  • Brazil
  • Drugs, Essential*
  • Female
  • Health Policy*
  • Health Services Accessibility
  • Humans
  • Middle Aged
  • Quality of Life

Substances

  • Drugs, Essential